IRIS Accounts Production v25.1.4.42 08047632 Board of Directors 1.5.24 30.4.25 30.4.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh080476322024-04-30080476322025-04-30080476322024-05-012025-04-30080476322023-04-30080476322023-05-012024-04-30080476322024-04-3008047632ns15:EnglandWales2024-05-012025-04-3008047632ns14:PoundSterling2024-05-012025-04-3008047632ns10:Director12024-05-012025-04-3008047632ns10:PrivateLimitedCompanyLtd2024-05-012025-04-3008047632ns10:SmallEntities2024-05-012025-04-3008047632ns10:AuditExempt-NoAccountantsReport2024-05-012025-04-3008047632ns10:SmallCompaniesRegimeForDirectorsReport2024-05-012025-04-3008047632ns10:SmallCompaniesRegimeForAccounts2024-05-012025-04-3008047632ns10:FullAccounts2024-05-012025-04-300804763212024-05-012025-04-3008047632ns10:Director22024-05-012025-04-3008047632ns10:RegisteredOffice2024-05-012025-04-3008047632ns5:CurrentFinancialInstruments2025-04-3008047632ns5:CurrentFinancialInstruments2024-04-3008047632ns5:ShareCapital2025-04-3008047632ns5:ShareCapital2024-04-3008047632ns5:RetainedEarningsAccumulatedLosses2025-04-3008047632ns5:RetainedEarningsAccumulatedLosses2024-04-3008047632ns5:NetGoodwill2024-05-012025-04-3008047632ns5:IntangibleAssetsOtherThanGoodwill2024-05-012025-04-3008047632ns5:PlantMachinery2024-05-012025-04-3008047632ns5:NetGoodwill2024-04-3008047632ns5:NetGoodwill2025-04-3008047632ns5:NetGoodwill2024-04-3008047632ns5:PlantMachinery2024-04-3008047632ns5:PlantMachinery2025-04-3008047632ns5:PlantMachinery2024-04-3008047632ns5:WithinOneYearns5:CurrentFinancialInstruments2025-04-3008047632ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3008047632ns5:RetainedEarningsAccumulatedLosses2024-04-3008047632ns5:RetainedEarningsAccumulatedLosses2024-05-012025-04-30
REGISTERED NUMBER: 08047632 (England and Wales)















FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 APRIL 2025

FOR

NEURO CASE MANAGEMENT CORPORATION LTD.

NEURO CASE MANAGEMENT CORPORATION LTD. (REGISTERED NUMBER: 08047632)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 30 APRIL 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


NEURO CASE MANAGEMENT CORPORATION LTD.

COMPANY INFORMATION
for the Year Ended 30 APRIL 2025







DIRECTORS: M S Gascoigne
Mrs M D Gascoigne





REGISTERED OFFICE: The Beeches
53 Kiveton Lane
Todwick
Sheffield
South Yorkshire
S26 1HJ





REGISTERED NUMBER: 08047632 (England and Wales)





ACCOUNTANTS: Brown & Co.
9 Sparken Hill
Worksop
Nottinghamshire
S80 1AX

NEURO CASE MANAGEMENT CORPORATION LTD. (REGISTERED NUMBER: 08047632)

BALANCE SHEET
30 APRIL 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 18,139 19,052
18,139 19,052

CURRENT ASSETS
Debtors 6 174,694 111,689
Cash at bank 10,072 56,881
184,766 168,570
CREDITORS
Amounts falling due within one year 7 197,977 156,899
NET CURRENT (LIABILITIES)/ASSETS (13,211 ) 11,671
TOTAL ASSETS LESS CURRENT
LIABILITIES

4,928

30,723

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 8 4,828 30,623
SHAREHOLDERS' FUNDS 4,928 30,723

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13 June 2025 and were signed on its behalf by:



M S Gascoigne - Director


NEURO CASE MANAGEMENT CORPORATION LTD. (REGISTERED NUMBER: 08047632)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 30 APRIL 2025

1. STATUTORY INFORMATION

Neuro Case Management Corporation Ltd. is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2015, is being amortised evenly over its estimated useful life of five years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance and 20% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


NEURO CASE MANAGEMENT CORPORATION LTD. (REGISTERED NUMBER: 08047632)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 30 APRIL 2025

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 45 (2024 - 87 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 May 2024
and 30 April 2025 4,065
AMORTISATION
At 1 May 2024
and 30 April 2025 4,065
NET BOOK VALUE
At 30 April 2025 -
At 30 April 2024 -

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 May 2024 101,316
Additions 3,783
At 30 April 2025 105,099
DEPRECIATION
At 1 May 2024 82,264
Charge for year 4,696
At 30 April 2025 86,960
NET BOOK VALUE
At 30 April 2025 18,139
At 30 April 2024 19,052

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 63,005 -
Other debtors 111,689 111,689
174,694 111,689

NEURO CASE MANAGEMENT CORPORATION LTD. (REGISTERED NUMBER: 08047632)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 30 APRIL 2025

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 13,096 -
Trade creditors 49,357 123,120
Taxation and social security 15,521 19,422
Other creditors 120,003 14,357
197,977 156,899

8. RESERVES
Retained
earnings
£   

At 1 May 2024 30,623
Deficit for the year (25,795 )
At 30 April 2025 4,828